20 participants
Venetoclax in Combination With Decitabine and Cedazuridine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-05-14
- Start Date:
- 2021-09-29
- Completion:
- 2027-05-31
Conditions
- Recurrent Acute Biphenotypic Leukemia
- Recurrent Acute Myeloid Leukemia
- Refractory Acute Biphenotypic Leukemia
- Refractory Acute Myeloid Leukemia
Interventions
- DRUG
No Results Yet